CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on enhancing the production of biopharmaceuticals by optimizing the downstream processing steps. It aims to reduce costs and environmental impact through innovative technologies like continuous chromatography and disposable systems, thereby improving patient access to essential drugs.
The scope of the project is the optimization of downstream process (DSP) for the production of Biopharmaceuticals.
Biopharmaceuticals have been successfully used as efficient therapeutic drugs for many pathophysiological conditions since the first recombinant product, insulin, was approved in 1982.
Despite its efficacy, accessibility is still limited due to extremely high costs.
In the production chain, capturing and purifying still represents a major bottleneck.
Consequently, improvements in th…
LEK FARMACEVTSKA DRUZBA DD
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
France, Molsheim
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Austria, Wien
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Austria, Kundl
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Germany, Karlsruhe
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
